KURTARAN, B. Et Al. 2019. Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey. International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , (Vienna, Austria).

KURTARAN, B., Sarigul, F., Cabalak, M., Kaya, S., Sari, N. D., KARSEN, H., ... Zerdali, E.(2019). Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey . International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Austria

KURTARAN, BEHİCE Et Al. "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey," International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Austria, 2019

KURTARAN, BEHİCE Et Al. "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Vienna, Austria, 2019

KURTARAN, B. Et Al. (2019) . "Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Vienna, Austria.

@conferencepaper{conferencepaper, author={BEHİCE KURTARAN Et Al. }, title={Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey}, congress name={International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)}, city={Vienna}, country={Austria}, year={2019}}